79
Views
2
CrossRef citations to date
0
Altmetric
Review

Application of caspofungin in China compared with amphotericin B and fluconazole

, , &
Pages 737-741 | Published online: 10 Sep 2014

References

  • YangHHuangWResearch progress of epidemiology and detection method for fungal infectionMedical Recapitulate20131929562970 Chinese
  • ChengJClinical analysis of 120 patients with diabetes and tuberculosis merger fungal infectionChinese and Foreign Medical Research201311223132 Chinese
  • GuoZChenHLouXHeXLiuXAcute myeloid leukemia invasive fungal infection caspofungin amphotericin BZhonghua Yi Yuan Gan Ran Xue Za Zhi2013231433693371 Chinese
  • HuangLTangXCaiWLeiCZhengFChenXAnalysis of death causes of 345 eases with HIV/AIDS in Guangdong areaZhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi20132715760 Chinese23855133
  • WangJWangXAnalysis on characteristics and prophylaxis of flucon-azoIe of fungal infection in ICUChina Modern Doctor20135118158160 Chinese
  • LiFWuLCaoBZhangYLiXLiuYSurveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011BMC Infect Dis201313135323899244
  • ChenLYLiaoSYKuoSCChanges in the incidence of candidaemia during 2000–2008 in a tertiary medical centre in Northern TaiwanJ Hosp Infect201181505321316800
  • BassettiMMerelliMRighiEEpidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and SpainJ Clin Microbiol201351124167417224108614
  • Chinese Medical AssociationThe guideline of diagnosis and treatment for invasive fungal infection patientsZhonghua Nei Ke Za Zhi20074611960966 Chinese
  • XingHSunDTianHComposition of hospital-acquired infections and community-acquired infections in a general hospital and analysis of drug susceptibilityZhonghua Yi Yuan Gan Ran Xue Za Zhi201323511421144 Chinese
  • LiuYLiuYTreatment outcomes of critically ill patients complicated with invasive fungal infectionsZhonghua Yi Yuan Gan Ran Xue Za Zhi2013231845844586 Chinese
  • LiuYZhangHChenJDaiYLiuTSpecies distribution and drug resistance in nosocomial infections with CandidaZhongguo Kang Sheng Su Za Zhi2013386473475 Chinese
  • LiYXiaZLiZFanQDistribution and drug resistance analysis on fungal infection in the urinary tractXian dai Yu fang Yi xue201340713301335 Chinese
  • WangXWangBZhaoCXiALiuRSongJClinical analysis on the diagnosis and treatment of AIDS with cryptococcal meningitis as the initial symptomsChinese General Practice2012153642184221 Chinese
  • ZhangXShiZZhangHThe analysis of deep fungal infectionChina Medical Herald2006330144145 Chinese
  • SangHNiRLiaoWCurrent advances in the treatment of systemic fungal infectionYi xue Yan jiu Sheng xue Bao20031614447 Chinese
  • KotaniTTakeuchiTMakinoSEfficacy and safety of liposomal amphotericin B for deep mycosis in patients with connective tissue diseaseJ Infect Chemother20131969169723325065
  • Adler-MooreJProffittRTAmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experienceJ Antimicrob Chemother200249213011801577
  • HerbrechtRDenningDWPattersonTFVoriconazole versus amphotericin B for primary therapy of invasive aspergillosisN Engl J Med2002347640841512167683
  • MoussetSBuchheidtDHeinzWTreatment of invasive fungal infections in cancer patients: updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Ann Hematol2014931133224026426
  • OnishiJMeinzMThompsonJDiscovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitorsAntimicrob Agents Chemother200044236837710639364
  • LinaresCEGiacomelliSRAltenhofenDAlvesSHMorschVMSchetingerMRFluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensisRev Soc Bras Med Trop201346675275824474018
  • Gomez-LopezAForastieroACendejas-BuenoEAn invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistanceMed Mycol201452331131924577012
  • BartizalKAbruzzoGTrainorCIn vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandinAntimicrob Agents Chemother1992368164816571416847
  • WangLLZhugeXXiaoGHZhangYHepatic safety caspofungin during treatment of invasive disease in elderly patientsChin Med J (Engl)201212512224022884162
  • ParamythiotouEFrantzeskakiFFlevariAArmaganidisADimopoulosGInvasive fungal infections in the ICU: how to approach, how to treatMolecules2014191108511924445340
  • MéanMMarchettiOCalandraTBench-to-bedside review: Candida infections in the intensive care unitCrit Care200812120418279532
  • KettDHShorrAFReboliACReismanALBiswasPSchlammHTAntidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasisCrit Care2011155R25322026929
  • MarcoFPfallerMAMesserSAJonesRNActivity of MK-099(L-743,872), a new echinocandin compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida sppDiagn Microbiol Infect Dis19983233379791755
  • DebonoMGordeeRSAntibiotics that inhibit fungal cell wall developmentAnnu Rev Microbiol1994484714977826015
  • BoucherHWGrollAHChiouCCWalshTJNewer systemic antifungal agents: pharmacokinetics, safety and efficacyDrugs200464181997202015341494
  • DenningDWEchinocandin antifungal drugsLancet200336293901142115114550704
  • ChenSCSlavinMASorrellTCEchinocandin antifungal drugs in fungal infections: a comparisonDrugs2011711114121175238
  • MigoyaEMMistryGCStoneJASafety and pharmacokinetics of higher doses of caspofungin in healthy adult participantsJ Clin Pharmacol201151220221120679501
  • StoneJAHollandSDWichershamPJSingle- and multiple-dose pharmacokinetics of caspofungin in healthy menAntimicrob Agents Chemother200246373974511850256
  • StevensDAAdvances in systemic antifungal therapyClin Dermatol201230665766123068153
  • BadaliHBonifazABarrón-TapiaTRhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosisMed Mycol201048569670320055741
  • PasticciMBBarchiesiFFallaniSClinical efficacy and tolerability of caspofungin in a renal transplant patient with Aspergillus flavus lung infection: case reportJ Chemother200618554955317127234
  • LillyCMWelchVLMayerTRanauroPMeisnerJLukeDREvaluation of intravenous voriconazole in patients with compromised renal functionBMC Infect Dis2013161314
  • van der ElstKCBrüggemannRJRodgersMGAlffenaarJWPlasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunctionTranspl Infect Dis201214444044322316392
  • SprietIMeyfroidtGMaleuxGVerslypeCWillemsLThe impact of a transjugular intrahepatic portosystemic shunt on the pharmacokinetics of caspofungin in a critically ill patientPharmacology2012905–624725023007631
  • ScottLJMicafungin: a review of its use in the prophylaxis and treatment of invasive Candida infectionsDrugs201272162141216523083111
  • Del PoetaMCruzMCCardenasMEPerfectJRHeitmanJSynergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformansAntimicrob Agents Chemother200044373974610681348
  • LiuWLiLSunYInteraction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitroAntimicrob Agents Chemother201256126414641623027186
  • RüpingMJVehreschildJJCornelyOAAntifungal treatment strategies in high risk patientsMycoses200851Suppl 2465118721331
  • ZhuAXueLCaspofungin vs fluconazole in the treatment of severe pulmonary fungal infection in intensive care unitChina Pharmacy2009202620472049 Chinese
  • LuoHFuGZhangYFengWHongPEfficacies of amphotericin B and caspofungin combined with intraconazole in treatment of invasive fungal infections inpatients with hematologic malignancies: a comparative studyZhonghua Yi Yuan Gan Ran Xue Za Zhi2013232255305532 Chinese
  • WangLZhugeXXiaGHZhangYAnalysis of efficacy and safety of caspofungin on treatment of invasive fungal disease in elderly patientsChin J Geriatr2013321213481350 Chinese
  • StoneEAFungHBKirschenbaumHLCaspofungin: an echinocandin antifungal agentClin Ther200224335137711952021
  • YangWOuHAdverse effect of caspofungin and management in patients with invasive aspergillosisJournal of China Medical University2007361108109 Chinese
  • WinklerMPratschkeJSchulzUCaspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational studyTranspl Infect Dis201012323023720070619